<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id><journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id><journal-id journal-id-type="publisher-id">nss</journal-id><journal-title-group><journal-title>Nature and Science of Sleep</journal-title></journal-title-group><issn pub-type="epub">1179-1608</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38836215</article-id><article-id pub-id-type="pmc">11149624</article-id><article-id pub-id-type="publisher-id">457679</article-id><article-id pub-id-type="doi">10.2147/NSS.S457679</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>The Association of High Arousal Threshold with Hypertension and Diabetes in Obstructive Sleep Apnea</article-title><alt-title alt-title-type="running-authors">Wang et al</alt-title><alt-title alt-title-type="running-title">Wang et al</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7219-2676</contrib-id><name><surname>Wang</surname><given-names>Donghao</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Yuting</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0003-5773-9033</contrib-id><name><surname>Gan</surname><given-names>Qiming</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6354-5794</contrib-id><name><surname>Su</surname><given-names>Xiaofen</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Haojie</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6867-4525</contrib-id><name><surname>Zhou</surname><given-names>Yanyan</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhuang</surname><given-names>Zhiyang</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jingcun</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Yutong</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4080-4754</contrib-id><name><surname>Zhao</surname><given-names>Dongxing</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1998-9958</contrib-id><name><surname>Zhang</surname><given-names>Nuofu</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><aff id="aff0001"><label>1</label><institution>State Key Laboratory of Respiratory Disease, Sleep Medicine Center, Guangzhou Institute of Respiratory Health, National Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country></aff><aff id="aff0002"><label>2</label><institution>The Clinical Medicine Department, Henan University</institution>, <addr-line>Zhengzhou</addr-line>, <country>People’s Republic of China</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Nuofu Zhang; Dongxing Zhao, <institution>State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Sleep Medicine Center, Guangzhou Institute of Respiratory Health, National Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country>, <phone content-type="general">Tel +86-13600460056</phone>; <phone content-type="general">+86-13650901411</phone>, Email nfzhanggird@163.com; rieast@163.com</corresp><fn id="ft0001"><label>*</label><p><citation_analysis attribute="neither">These authors contributed equally to this work</citation_analysis></p></fn></author-notes><pub-date pub-type="epub"><day>31</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>16</volume><fpage>653</fpage><lpage>662</lpage><history><date date-type="received"><day>02</day><month>1</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>5</month><year>2024</year></date></history><permissions><copyright-statement>© 2024 Wang et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Wang et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec><title>Objective</title><p><citation_analysis attribute="neither">Compared to low arousal threshold (AT), high AT is an easily overlooked characteristic for obstructive sleep apnea (OSA) severity estimation. This study aims to evaluate the relationship between high AT, hypertension and diabetes in OSA, compared to those with apnea–hypopnea index (AHI).</citation_analysis></p></sec><sec><title>Methods</title><p><citation_analysis attribute="neither">A total of 3400 adults diagnosed with OSA were retrospectively recruited. Propensity score matching (PSM) was conducted to further categorize these patients into the low and high AT groups based on the strategy established by previous literature. The different degrees of AHI and quantified AT (AT score) were subsequently measured. The correlation of AT and AHI with the occurrence of various comorbidities in OSA was estimated by logistic regression analysis with odds ratio (OR).</citation_analysis></p></sec><sec><title>Results</title><p><citation_analysis attribute="positive">After PSM, 938 pairs of patients arose. The median AT score of high and low AT group was 21.7 and 12.2 scores, and the adjusted OR of high AT for hypertension and diabetes was 1.31 (95% CI = 1.07–1.62, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01) and 1.45 (95% CI = 1.01–2.08, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05), respectively. Compared to low AT score group, the OR significantly increased in patients with very high AT score (30 ≤ AT score), especially for diabetes (OR = 1.79, 95% CI = 1.02–3.13, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> &lt; 0.05). The significant association was not observed in AHI with increasing prevalent diabetes.</citation_analysis></p></sec><sec><title>Conclusion</title><p><citation_analysis attribute="neither">Higher AT is significantly associated with increased prevalence of hypertension and diabetes in patients with OSA. Compared with AHI, AT score is a potentially comprehensive indicator for better evaluating the relationship between OSA and related comorbidities.</citation_analysis></p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>obstructive sleep apnea</kwd><kwd>arousal threshold</kwd><kwd>apnea–hypopnea index</kwd><kwd>hypertension</kwd><kwd>diabetes</kwd></kwd-group><funding-group><award-group><funding-source>
<institution-wrap><institution>Basic Research Project (Dengfeng hospital) jointly Funded by Guangzhou City and the School</institution></institution-wrap>
</funding-source></award-group><award-group><funding-source>
<institution-wrap><institution>the Natural Science Foundation of Guangdong Province China</institution></institution-wrap>
</funding-source></award-group><funding-statement>This research project was supported by Basic Research Project (Dengfeng hospital) jointly Funded by Guangzhou City and the School (No.202201020586) and the Natural Science Foundation of Guangdong Province China (No. 2019A1515010981).</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="4"/><ref-count count="51"/><page-count count="10"/></counts></article-meta></front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Obstructive sleep apnea (OSA) affects up to one billion individuals globally,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="negative"> which is an independent risk factor for a number of disorders, especially cardiovascular and metabolic diseases such as hypertension and diabetes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="negative"> Patients with untreated severe OSA had a higher risk of fatal cardiovascular events.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> The apnea–hypopnea index (AHI) is currently considered the gold standard for diagnosing OSA, as it measures the frequency of apneas and hypopneas during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="negative"> A prospective cohort study, which categorized OSA severity by AHI, showed that patients with moderate and severe OSA had a higher 10-year risk of fatal cardiovascular disease.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> Nevertheless, AHI fails to provide information about the duration and severity of blood gas changes and comprehensively explain the characteristics of OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="negative"> Some studies have found that patients sharing the same AHI displayed considerable variation in pathogenesis, comorbidity rates, and prognosis since OSA is a heterogeneous disease, suggesting that AHI may have limitation to examine the relationship between OSA and relevant comorbidities.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="negative"> Recently, researchers have proposed some new indicator including hypoxic burden (HB), ventilation burden, sleep arousal burden, and sleep breathing impairment index, which are more closely associated with the risk of comorbidities than AHI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> In a large cohort study, Trzepizur et al found that HB and T90 were the better indicators associated with cardiovascular morbidity than AHI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="positive"> Moreover, the studies of endotype have revealed that in addition to anatomical factors, non-anatomical factors such as high loop gain, low arousal threshold, critical closing pressure, and upper airway muscle reactiveness play significant roles in OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Arousal threshold (AT) is characterized by the amount of ventilatory drive in response to a respiratory stimulus that ends in excitation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither"> Frequent arousals due to low AT can lead to sleep fragmentation and ventilation instability.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> As previous studies shown, approximately one-third to half of patients with OSA exhibit low AT.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> Cortical arousal induces rapid physiological changes, facilitating prompt alleviation of acute respiratory episodes and their associated consequences. Previous research indicated that a higher prevalence of low AT in patients with OSA and asthma or COPD compared to those with OSA alone.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="positive"> A higher AT, more frequently observed in patients with more severe OSA, may result in more severe partial airway obstruction, lower oxygen saturation and hypercapnia during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="positive"> Heinzer RC et al demonstrated that in patients with a severely compromised pharyngeal airway, an elevated arousal threshold would likely prolong the duration of the apnea as an arousal which will probably be needed to reopen the collapsed upper airway.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> These pathophysiological mechanisms are related to adverse consequences such as endothelial dysfunction, sympathetic excitation, inflammation, oxidative stress, and metabolic dysfunction,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> which eventually develop to multiple comorbidities.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="positive"> Zinchuk et al reported that patients with OSA and high AT were more likely to comorbid with hypertension and other comorbidities, while the results were not statistically significant after adjusting for BMI values.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="positive"> It remains unclear with less evidence that whether high AT is associated with increased prevalent comorbidities such as hypertension and diabetes in patients with OSA. Another important issue is that whether there exists a cut-off point to distinguish between normal threshold and pathological high threshold. We hypothesized that high AT would be a greater risk factor for hypertension and diabetes than high AHI.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Methods</title>
      <sec id="s0002-s2001">
        <title>Participants</title>
        <p><citation_analysis attribute="positive">All study subjects were enrolled from Jan 2022 to Jun 2023, at the Sleep Medicine Center of the First Affiliated Hospital of Guangzhou Medical University, including adults referred for polysomnography (PSG) evaluation because of snoring or daytime sleepiness and the suspicion of sleep-disordered breathing by the primary care physician. The procedures followed in this study were in accordance with the Declaration of Helsinki, approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University, Ethics Approval No. 05, 2017, and all patients have signed informed consent forms. The primary inclusion criteria were adults diagnosed with OSA, with completed overnight PSG data, completely independent behavioral and cognitive functioning, and electronic or paper records of past medical history for diagnosing other comorbidities such as hypertension and diabetes. The exclusion criteria were (1) previous diagnosis of or treatment for OSA; (2) respiratory events dominated by central or mixed sleep apnea; (3) total sleep time less than 6 hours; (4) usage of hypnotics before PSG; and (5) patients with restless leg syndrome, narcolepsy and other sleep disorders. All participants met the inclusion and exclusion criteria. The flow chart of this study is shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">.
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">Study flowchart.</citation_analysis></p></caption><graphic xlink:href="NSS-16-653-g0001" content-type="print-only" position="float"/><attrib><bold>Abbreviation</bold>: OSA, obstructive sleep apnea; PSM, propensity score matching; PSG, polysomnography.</attrib></fig></citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Data Extraction</title>
        <p><citation_analysis attribute="neither">We retrospectively collected the variables associated with OSA: demographic characteristics and lifestyles, including age, gender, weight, body mass index (BMI), smoking history, and alcohol consumption. After checking the medical history, we confirmed the comorbidities of hypertension, diabetes, coronary heart disease (CHD) and cerebrovascular disease (CVD). A typical definition of hypertension relies on an average systolic BP (SBP) of ≥140 mm Hg, diastolic BP (DBP) of ≥90 mm Hg, or self-reported usage of antihypertensive medication.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither"> The diagnostic criteria for diabetes mellitus are as follows: Fasting Plasma Glucose (FPG): Fasting blood glucose level ≥7.0 mmol/L (126 mg/dL). Oral Glucose Tolerance Test (OGTT): 2-hour postprandial blood glucose level ≥11.1 mmol/L (200 mg/dL). Random Plasma Glucose: Random blood glucose level ≥11.1 mmol/L (200 mg/dL) in the presence of classic symptoms of diabetes like polyuria, polydipsia, unexplained weight loss, etc. Meeting any one of the above criteria may lead to a preliminary diagnosis of diabetes mellitus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> CHD is defined as a cardiovascular disease caused by reduced blood flow to the heart muscle due to narrowed or blocked coronary arteries, and CVD as the diseases of the blood vessels supplying the brain, including stroke.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="positive"> Data extraction from PSG included AHI, oxygen desaturation index (ODI), total sleep time spent with arterial oxygen saturation &lt;90% (T90%), wakeup after sleep onset (WASO), the number of microarousal events per hour of recording (MAI), the percentage of stage 1, 2, 3 and rapid eye movement sleep in total sleep time (N1%, N2%, N3%, REM%), mean pulse oxygen saturation (MSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">), lowest pulse oxygen saturation (LSpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">) and the F</citation_analysis><citation_analysis attribute="positive"><sub>hypopnea,</sub></citation_analysis><citation_analysis attribute="neither"> which is defined as the fraction of the respiratory events that were hypopnea.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>PSG Parameters</title>
        <p><citation_analysis attribute="positive">Sleep studies were performed at sleep center using Alice 6 PSG (Philips Wellcome, USA) for at least 7 hours, and the use of alcohol, coffee, sedatives and hypnotics was prohibited on the same day. The monitoring indicator included electroencephalogram, electromyography, blood oxygen saturation, electrooculogram, electrocardiogram, snoring, mouth airflow, nasal airflow, chest breathing and body position.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> All data were separately manually analyzed by two trained sleep professionals, according to the American Academy of Sleep Medicine Manual for Scoring Sleep and Associated events in 2017.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> The minimum duration of respiratory events was 10s. Apneas were defined as a cessation of airflow for 10s, while hypopneas were defined as a reduction of the airflow signal amplitude ≥30%, associated with a 3% oxygen desaturation. The AHI was calculated as the number of apneas and hypopneas divided by the recording duration in hours. OSA was defined as an AHI ≥ 5 events/h. AHI ≥5 and &lt;15 events/h, AHI ≥15 and &lt;30 events/h and AHI ≥30 events/h were classified as low, moderate and high, respectively.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>Arousal Threshold</title>
        <p><citation_analysis attribute="neither">To assess the AT, we used a simple and novel method based on PSG data and clinical characteristics which has been widely used in previous studies.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither"> Low AT was determined in a paitent with OSA if two or more than two of the following three criterion were met: AHI &lt; 30 events/h, a nadir SpO2 &gt;82.5%, and the proportion of hypopneas &gt;58.3%. Otherwise, the rest were considered to have high AT.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="positive"> In addition, as the multiple logistic regression shown in the study of Edwards et al, the formula for quantifying AT score is as followed (where male sex = 1 and female sex = 0):</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><disp-formula-group><disp-formula id="um0001"><alternatives><graphic xlink:href="NSS-16-653-e0001.jpg" position="float"/><tex-math id="Tex001">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$$\rm\eqalign{ &amp; AT\;score\; = \;0 - [- 65.39\; + \;0.06*age\; + \;(3.69*sex) \cr &amp; - (0.03*BMI) - (0.11*AHI)\; + \;(0.53*LSaO2)\; \cr &amp; + \;(0.09*{F_{hypopnea}}*100\rm\%)] \cr} $$
\end{document}</tex-math></alternatives></disp-formula></disp-formula-group></citation_analysis></p>
        <p><citation_analysis attribute="positive">As a higher arousal threshold indicates a larger absolute value, in order to better clarify and understand the relationship between the AT score and different variables, we converted the AT score to a positive absolute number. We defined low AT as less than 15 scores, high AT as 15 to 30 scores, and very high AT as larger than 30 scores, respectively.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2005">
        <title>Statistical Analysis</title>
        <p><citation_analysis attribute="negative">In order to minimize the confounding effect of demographic characteristics and hypoxia-related PSG parameters on the relationship between high AT and various comorbidities, we performed a 1:1 propensity score matching (PSM) with a caliper value of 0.01. The selected matching factor were based on risk factor affecting the occurrence of hypertension and diabetes derived from previous studies,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="positive"> including age, gender, BMI, smoking, alcohol consumption, ODI and T90%. All analyses were conducted using SPSS version 26.0 software. The continuous data showed non-normal distributions and thus were presented as median (interquartile range, IQR: P25, P75). The non-parametric tests and Mann–Whitney </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">U</italic></citation_analysis><citation_analysis attribute="positive">-test were employed to compare group difference. Categorical variables were expressed as counts (%) and compared between groups using the chi-square test for valuating unadjusted odds ratio (OR). The multiple logistic regression models were used to examine the adjusted OR of high AT (reference as low AT), very high and high AT score (reference as low AT score), high AHI (reference as low AHI) for different comorbidities. ODI and T90% were selected as confounding factors to adjusted for the indicator of hypoxia. Model 1 was adjusted for age, BMI, male%, smoking, alcohol consumption; Model 2 was adjusted for ODI and T90% plus all covariates in Model 1. The </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> value of less than 0.05 was determined to be statistically significant.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Participants</title>
        <p><citation_analysis attribute="positive">The characteristics of participants categorized by the levels of AT are shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="positive">. A total of 3400 participants were recruited, with 1845 classified in the high AT group and 1555 in the low AT group. After performing PSM, both groups included 938 subjects and their age, ODI, BMI, the proportion of male, smoking history and alcohol consumption history were comparable and did not show statistical significance. Statistically significant differences (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) were still observed in AHI (39.1 vs 14.9 events/h), LSpO2 (74.5 vs 84.0%), and F</citation_analysis><citation_analysis attribute="positive"><sub>hypopnea</sub></citation_analysis><citation_analysis attribute="neither"> (38.6 vs 68.6%) between high and low AT group, since the assessment of arousal threshold was based on these three features. The AT score of high and low AT group was 21.7 (17.2, 28.7) and 12.2 (9.4, 15.1), respectively. In high AT group, 299 (31.9%) and 79 (8.4%) patients had the coexistence of hypertension and diabetes, while 250 (26.7%) and 55 (5.9%) patients were complicated with hypertension and diabetes, respectively, in low AT group. The occurrence of hypertension and diabetes were statistically different between the two groups (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.013, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.031), and there were no statistical significance in CHD and CVD after PSM.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Baseline Characteristics of Participants with OSA Stratified by AT Before PSM (n=3400) and After PSM (n=1876)</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th colspan="3" rowspan="1">Before PSM</th><th colspan="3" rowspan="1">After PSM</th></tr><tr><th rowspan="1" colspan="1">High AT Group (n = 1845)</th><th rowspan="1" colspan="1">Low AT Group (n = 1555)</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th rowspan="1" colspan="1">High AT Group (n = 938)</th><th rowspan="1" colspan="1">Low AT Group (n = 938)</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Demographic and clinical characteristics</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Age, years</td><td rowspan="1" colspan="1">46.0 (36.0, 57.0)</td><td rowspan="1" colspan="1">49.0 (38.0, 59.0)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">47.0 (37.0, 58.0)</td><td rowspan="1" colspan="1">48.0 (37.0, 58.0)</td><td rowspan="1" colspan="1">0.867</td></tr><tr><td rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td rowspan="1" colspan="1">27.7 (25.4, 30.1)</td><td rowspan="1" colspan="1">26.2 (23.8, 28.5)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">26.6 (24.5, 29.1)</td><td rowspan="1" colspan="1">26.9 (24.6, 29.1)</td><td rowspan="1" colspan="1">0.498</td></tr><tr><td rowspan="1" colspan="1">NC, cm</td><td rowspan="1" colspan="1">40.0 (37.0, 42.0)</td><td rowspan="1" colspan="1">38.0 (35.5, 40.0)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">39.0 (37.0, 41.0)</td><td rowspan="1" colspan="1">39.0 (37.0, 41.0)</td><td rowspan="1" colspan="1">0.738</td></tr><tr><td rowspan="1" colspan="1">WC, cm</td><td rowspan="1" colspan="1">97.0 (91.0, 104.0)</td><td rowspan="1" colspan="1">94.0 (87.0, 100.0)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">96.0 (89.0, 102.0)</td><td rowspan="1" colspan="1">96.0 (90.0, 102.0)</td><td rowspan="1" colspan="1">0.291</td></tr><tr><td rowspan="1" colspan="1">Male, n (%)</td><td rowspan="1" colspan="1">1588 (86.1)</td><td rowspan="1" colspan="1">1092 (70.3)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">772 (82.3)</td><td rowspan="1" colspan="1">781 (83.3)</td><td rowspan="1" colspan="1">0.582</td></tr><tr><td rowspan="1" colspan="1">Smoking, n (%)</td><td rowspan="1" colspan="1">709 (38.4)</td><td rowspan="1" colspan="1">441 (28.4)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">352 (37.5)</td><td rowspan="1" colspan="1">327 (34.9)</td><td rowspan="1" colspan="1">0.230</td></tr><tr><td rowspan="1" colspan="1">Alcohol consumption, n (%)</td><td rowspan="1" colspan="1">574 (31.1)</td><td rowspan="1" colspan="1">373 (24.0)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">251 (26.8)</td><td rowspan="1" colspan="1">271 (28.9)</td><td rowspan="1" colspan="1">0.303</td></tr><tr><td rowspan="1" colspan="1"><bold>PSG parameters</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">AHI, events/h</td><td rowspan="1" colspan="1">48.1 (31.5, 64.5)</td><td rowspan="1" colspan="1">12.9 (8.5, 19.9)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">39.1 (23.4, 59.4)</td><td rowspan="1" colspan="1">14.9 (9.4, 22.5)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ODI, events/h</td><td rowspan="1" colspan="1">44.9 (25.4, 64.1)</td><td rowspan="1" colspan="1">18.0 (10.1, 31.9)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">27.6 (14.7, 45.5)</td><td rowspan="1" colspan="1">25.2 (14.9, 42.1)</td><td rowspan="1" colspan="1">0.479</td></tr><tr><td rowspan="1" colspan="1">T90%, min</td><td rowspan="1" colspan="1">28.4 (7.9, 68.2)</td><td rowspan="1" colspan="1">1.5 (0.3, 6.2)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">10.9 (3.5, 28.7)</td><td rowspan="1" colspan="1">2.0 (0.4, 8.7)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">TST, min</td><td rowspan="1" colspan="1">429.0 (383.0, 471.0)</td><td rowspan="1" colspan="1">409.0 (358.0, 451.3)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">426.0 (385.0, 468.0)</td><td rowspan="1" colspan="1">411.2 (359.0, 454.0)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">MAI, events/h</td><td rowspan="1" colspan="1">29.8 (18.0, 45.4)</td><td rowspan="1" colspan="1">13.0 (8.5, 19.3)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">23.0 (14.0, 39.8)</td><td rowspan="1" colspan="1">14.7 (9.5, 22.0)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">WASO, min</td><td rowspan="1" colspan="1">35.0 (14.0, 71.5)</td><td rowspan="1" colspan="1">36.0 (15.0, 77.5)</td><td rowspan="1" colspan="1">0.145</td><td rowspan="1" colspan="1">33.5 (13.0, 72.8)</td><td rowspan="1" colspan="1">31.0 (10.0, 70.5)</td><td rowspan="1" colspan="1">0.332</td></tr><tr><td rowspan="1" colspan="1">Sleep efficiency, %</td><td rowspan="1" colspan="1">88.7 (80.8, 94.7)</td><td rowspan="1" colspan="1">86.9 (77.6, 93.1)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">86.9 (78.3, 92.9)</td><td rowspan="1" colspan="1">86.2 (77.0, 92.9)</td><td rowspan="1" colspan="1">0.095</td></tr><tr><td rowspan="1" colspan="1">N1, %</td><td rowspan="1" colspan="1">20.4 (11.0, 36.0)</td><td rowspan="1" colspan="1">16.6 (10.1, 27.5)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">26.5 (13.3, 41.0)</td><td rowspan="1" colspan="1">17.6 (10.8, 29.6)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">N2, %</td><td rowspan="1" colspan="1">55.9 (41.9, 68.2)</td><td rowspan="1" colspan="1">56.3 (44.3, 65.7)</td><td rowspan="1" colspan="1">0.085</td><td rowspan="1" colspan="1">48.1 (36.3, 60.2)</td><td rowspan="1" colspan="1">55.1 (43.0, 65.6)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">N3, %</td><td rowspan="1" colspan="1">3.9 (0.0, 11.3)</td><td rowspan="1" colspan="1">8.0 (1.4, 15.1)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">8.4 (2.2, 15.2)</td><td rowspan="1" colspan="1">8.0 (1.2, 15.2)</td><td rowspan="1" colspan="1">0.317</td></tr><tr><td rowspan="1" colspan="1">REM, %</td><td rowspan="1" colspan="1">13.6 (9.0, 18.2)</td><td rowspan="1" colspan="1">15.0 (9.9, 19.7)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">12.9 (7.3, 18.0)</td><td rowspan="1" colspan="1">14.3 (9.4, 19.0)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">MSpO<sub>2</sub>, %</td><td rowspan="1" colspan="1">94.0 (92.0, 95.0)</td><td rowspan="1" colspan="1">95.0 (93.0, 96.0)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">95.0 (93.0, 96.0)</td><td rowspan="1" colspan="1">94.0 (93.0, 96.0)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">LSpO<sub>2</sub>, %</td><td rowspan="1" colspan="1">71.0 (62.0, 79.0)</td><td rowspan="1" colspan="1">85.0 (82.0, 88.0)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">74.5 (64.5, 80.0)</td><td rowspan="1" colspan="1">84.0 (80.0, 87.0)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">F<sub>hypopnea</sub>, %</td><td rowspan="1" colspan="1">30.7 (12.2, 51.5)</td><td rowspan="1" colspan="1">71.9 (47.2, 87.7)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">38.6 (20.9, 55.6)</td><td rowspan="1" colspan="1">68.6 (38.1, 85.1)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">AT Score</td><td rowspan="1" colspan="1">24.4 (18.7, 32.0)</td><td rowspan="1" colspan="1">11.6 (9.0, 14.6)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">21.7 (17.2, 28.7)</td><td rowspan="1" colspan="1">12.2 (9.4, 15.1)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"><bold>Comorbidities</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Hypertension, n (%)</td><td rowspan="1" colspan="1">584 (31.6)</td><td rowspan="1" colspan="1">403 (25.9)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">299 (31.9)</td><td rowspan="1" colspan="1">250 (26.7)</td><td rowspan="1" colspan="1">0.013</td></tr><tr><td rowspan="1" colspan="1">Diabetes, n (%)</td><td rowspan="1" colspan="1">141 (7.6)</td><td rowspan="1" colspan="1">105 (6.8)</td><td rowspan="1" colspan="1">0.323</td><td rowspan="1" colspan="1">79 (8.4)</td><td rowspan="1" colspan="1">55 (5.9)</td><td rowspan="1" colspan="1">0.031</td></tr><tr><td rowspan="1" colspan="1">CHD, n (%)</td><td rowspan="1" colspan="1">95 (5.1)</td><td rowspan="1" colspan="1">108 (6.9)</td><td rowspan="1" colspan="1">0.027</td><td rowspan="1" colspan="1">47 (5.0)</td><td rowspan="1" colspan="1">60 (6.4)</td><td rowspan="1" colspan="1">0.196</td></tr><tr><td rowspan="1" colspan="1">CVD, n (%)</td><td rowspan="1" colspan="1">70 (3.8)</td><td rowspan="1" colspan="1">79 (5.1)</td><td rowspan="1" colspan="1">0.067</td><td rowspan="1" colspan="1">30 (3.2)</td><td rowspan="1" colspan="1">41 (4.4)</td><td rowspan="1" colspan="1">0.183</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Values were expressed as median (interquartile range in brackets) or count (percentage). T90%: cumulative percentages of time spent at arterial oxygen saturation below 90%; MSpO2: mean pulse oxygen saturation; LSaO2: lowest arterial oxygen saturation; WASO: wake after sleep onset; MAI: microarousal index; TST: total sleep time; N1%, N2%, N3%, REM%: the percentage of stage 1, 2, 3 and rapid eye movement sleep in total sleep time; F</citation_analysis><citation_analysis attribute="positive"><sub>hypopnea</sub></citation_analysis><citation_analysis attribute="neither">: fraction of the respiratory events that were hypopnea.</citation_analysis></p></fn><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: AT, arousal threshold; PSM, propensity score matching; BMI, body mass index; NC, neck circumstance; WC, waist circumstance; PSG, polysomnography; AHI, apnea–hypopnea index; ODI, oxygen desaturation index. CHD, coronary heart disease; CVD, cerebrovascular disease.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>The Association Between High AT and the Occurrence of Hypertension, Diabetes</title>
        <p><citation_analysis attribute="positive">The results of multivariate logistic regression adjusted for age, BMI, male%, smoking, alcohol consumption, ODI, and T90% are displayed in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">. Before PSM, patients with high AT had an increased occurrence of hypertension with an unadjusted OR of 1.32 (95% CI = 1.14–1.54) (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> &lt; 0.01) and adjusted OR of 1.36 (95% CI = 1.14–1.62) (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> &lt; 0.01). After PSM, the results were still statistically significant, although the unadjusted and adjusted OR decreased to 1.29 (95% CI = 1.06–1.55) (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05) and 1.31 (95% CI = 1.07–1.62) (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> &lt; 0.01), respectively. On the other hand, high AT was not associated with the higher prevalent diabetes before PSM, while the results after PSM indicated statistically significant relationships with the unadjusted OR of 1.48 (95% CI = 1.03–2.11) (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> &lt; 0.05) and adjusted OR of 1.45 (95% CI = 1.01–2.08) (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05), respectively.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0002"><label>Table 2</label><caption><p><citation_analysis attribute="neither">The Relationship Between High at and the Occurrence of Hypertension, Diabetes, CHD and CVD in Patients with OSA Before and After PSM, Compared with Low AT</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th colspan="2" rowspan="1">Before PSM</th><th colspan="2" rowspan="1">After PSM</th></tr><tr><th rowspan="1" colspan="1">Unadjusted OR (95% CI)</th><th rowspan="1" colspan="1">Adjusted OR (95% CI)</th><th rowspan="1" colspan="1">Unadjusted OR (95% CI)</th><th rowspan="1" colspan="1">Adjusted OR (95% CI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1"><bold>1.32</bold> (1.14–1.54)**</td><td rowspan="1" colspan="1"><bold>1.36</bold> (1.14–1.62**</td><td rowspan="1" colspan="1"><bold>1.29</bold> (1.06–1.57)*</td><td rowspan="1" colspan="1"><bold>1.31</bold> (1.07–1.62)**</td></tr><tr><td rowspan="1" colspan="1">Diabetes</td><td rowspan="1" colspan="1">1.14 (0.88–1.48)</td><td rowspan="1" colspan="1">1.23 (0.91–1.65)</td><td rowspan="1" colspan="1"><bold>1.48</bold> (1.03–2.11)*</td><td rowspan="1" colspan="1"><bold>1.45</bold> (1.01–2.08)*</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: The adjusted ORs for various comorbidities were adjusted by age, BMI, male%, smoking, ODI and T90%. alcohol consumption. Bolded numbers indicated the results were statistically significant, * indicated </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> value &lt;0.05, and ** indicated </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> value &lt;0.01.</citation_analysis></p></fn><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: AT, arousal threshold; PSM, propensity score matching; OR, odds ratio; CI, confidence interval.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
        <p><citation_analysis attribute="positive">Subgroup analyses were subsequently conducted, the result of male subgroup showed that high AT was a risk factor for hypertension and diabetes (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=457679.docx" ext-link-type="uri">Table S1</ext-link></underline></citation_analysis><citation_analysis attribute="neither">). In subgroup analyses according to BMI and age, only high AT was associated with the more frequency of hypertension in BMI &lt; 27 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> and Age &lt;60 years subgroups (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=457679.docx" ext-link-type="uri">Tables S2</ext-link></underline></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=457679.docx" ext-link-type="uri">S3</ext-link></underline></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>The Association of AT Score and AHI with the Occurrence of Hypertension and Diabetes</title>
        <p><citation_analysis attribute="neither">Compared with low AT score (AT score ≤ 15) after PSM, high- (15 ≤ AT score &lt; 30) and very high AT score (30 ≤ AT score) were both significantly associated with hypertension, and the association was strengthened with the increase of AT score (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">). In parallel, only high AHI (AHI ≥ 30) had a higher odds of hypertension than low AHI (5 ≤ AT score &lt; 15) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">). The results of subgroups by gender, BMI and age for AT score were similar to those for high AT (compared with low AT), but the stepwise increase in the odds of hypertension were more remarkable, especially in BMI &lt; 27 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> subgroup (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=457679.docx" ext-link-type="uri">Tables S4</ext-link>-<ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=457679.docx" ext-link-type="uri">S6</ext-link></underline></citation_analysis><citation_analysis attribute="neither">). All ORs were similar in both Model 1 and Model 2.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0003"><label>Table 3</label><caption><p><citation_analysis attribute="neither">The Relationship Between the Different Threshold of AT Score, AHI and the Occurrence of Hypertension in Patients with OSA (After PSM)</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Predictors/Threshold for the Risk of Hypertension</th><th rowspan="2" colspan="1">n</th><th colspan="2" rowspan="1">Adjusted OR (95% CI)</th></tr><tr><th rowspan="1" colspan="1">Model 1</th><th rowspan="1" colspan="1">Model 2</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>AT score</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> AT score ≤ 15</td><td rowspan="1" colspan="1">810</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1"> 15 ≤ AT score &lt; 30</td><td rowspan="1" colspan="1">852</td><td rowspan="1" colspan="1"><bold>1.29</bold> (1.03–1.62)*</td><td rowspan="1" colspan="1"><bold>1.31</bold> (1.04–1.64)*</td></tr><tr><td rowspan="1" colspan="1"> 30 ≤ AT score</td><td rowspan="1" colspan="1">214</td><td rowspan="1" colspan="1"><bold>1.45</bold> (1.02–2.06)*</td><td rowspan="1" colspan="1"><bold>1.47</bold> (1.02–2.10)*</td></tr><tr><td rowspan="1" colspan="1"><bold>AHI</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 5 ≤ AHI &lt; 15</td><td rowspan="1" colspan="1">592</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1"> 15 ≤ AHI &lt; 30</td><td rowspan="1" colspan="1">603</td><td rowspan="1" colspan="1">1.11 (0.85–1.44)</td><td rowspan="1" colspan="1">1.11 (0.85–1.44)</td></tr><tr><td rowspan="1" colspan="1"> AHI ≥ 30</td><td rowspan="1" colspan="1">681</td><td rowspan="1" colspan="1"><bold>1.34</bold> (1.04–1.73)*</td><td rowspan="1" colspan="1"><bold>1.35</bold> (1.04–1.74)*</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Low AT score and low AHI were considered as the reference. Model 1 was adjusted for age, BMI, male%, smoking, alcohol consumption; Model 2: Model 1 + ODI and T90%. Bolded numbers indicated the results were statistically significant, and * indicated </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> value &lt;0.05.</citation_analysis></p></fn><fn id="tfn0006"><p><citation_analysis attribute="positive"><bold>Abbreviation</bold></citation_analysis><citation_analysis attribute="neither">: AT, arousal threshold; AHI, apnea hypopnea index; OSA, obstructive sleep apnea; PSM, propensity score matching; OR, odds ratio; CI, confidence interval.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
        <p><citation_analysis attribute="neither">For another, the stratification of AHI did not effectively identify the prevalent diabetes (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="positive">). Compared with low AT score, patients with OSA and very high AT score were more likely to comorbid with diabetes, with the OR of 1.79 (Model 2, 95% CI = 1.02–3.13, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05). The OR dramatically increased to 3.58 (Model 2, 95% CI = 1.06–12.09, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05) in the subgroup of Age &gt;60 years (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=457679.docx" ext-link-type="uri">Table S7</ext-link></underline></citation_analysis><citation_analysis attribute="positive">). There were no significant differences between the subgroups by gender and BMI (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=457679.docx" ext-link-type="uri">Tables S8</ext-link></underline></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=457679.docx" ext-link-type="uri">S9</ext-link></underline></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0004"><label>Table 4</label><caption><p><citation_analysis attribute="neither">The Relationship Between the Different Threshold of AT Score, AHI and the Occurrence of Diabetes in Patients with OSA (After PSM)</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Predictors/Threshold for the Risk of Diabetes</th><th rowspan="2" colspan="1">n</th><th colspan="2" rowspan="1">Adjusted OR (95% CI)</th></tr><tr><th rowspan="1" colspan="1">Model 1</th><th rowspan="1" colspan="1">Model 2</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>AT score</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> AT score ≤ 15</td><td rowspan="1" colspan="1">810</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1"> 15 ≤ AT score &lt; 30</td><td rowspan="1" colspan="1">852</td><td rowspan="1" colspan="1">1.05 (0.70–1.57)</td><td rowspan="1" colspan="1">1.07 (0.67–1.51)</td></tr><tr><td rowspan="1" colspan="1"> 30 ≤ AT score</td><td rowspan="1" colspan="1">214</td><td rowspan="1" colspan="1"><bold>1.90</bold> (1.11–3.27)*</td><td rowspan="1" colspan="1"><bold>1.79</bold> (1.02–3.13)*</td></tr><tr><td rowspan="1" colspan="1"><bold>AHI</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 5 ≤ AHI &lt; 15</td><td rowspan="1" colspan="1">592</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1"> 15 ≤ AHI &lt; 30</td><td rowspan="1" colspan="1">603</td><td rowspan="1" colspan="1">1.10 (0.69–1.76)</td><td rowspan="1" colspan="1">1.09 (0.68–1.75)</td></tr><tr><td rowspan="1" colspan="1"> AHI ≥ 30</td><td rowspan="1" colspan="1">681</td><td rowspan="1" colspan="1">1.29 (0.83–2.00)</td><td rowspan="1" colspan="1">1.23 (0.79–1.93)</td></tr></tbody></table><table-wrap-foot><fn id="tfn0007"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Low AT score and low AHI were considered as the reference. Model 1 was adjusted for age, BMI, male%, smoking, alcohol consumption; Model 2: Model 1 + ODI and T90%.; Bolded numbers indicated the results were statistically significant, and *indicated </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> value &lt;0.05.</citation_analysis></p></fn><fn id="tfn0008"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: AT, arousal threshold; AHI, apnea hypopnea index; OSA, obstructive sleep apnea; PSM, propensity score matching; OR, odds ratio; CI, confidence interval.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="positive">This retrospective study evaluated the relationship between AT and the comorbidities including hypertension and diabetes in patients with OSA. Additionally, AT score was served as a potential predictor for exploring the deeper association. In the study, we found a stronger correlation between higher AT and the occurrence of hypertension and diabetes in OSA patients than that of AHI. When classified all patients according to AT score, the result suggested that more frequency of hypertension and diabetes were observed in those with very high AT score, compared to low AT score group. Previous study indicated that patients with OSA and high AT combined with a higher prevalence of hypertension and diabetes, but there were no statistically significant after adjustment for BMI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="negative"> PSM was performed to minimize the selection bias and confounding effect from demographic characteristics and hypoxia indicators in our study, in order to better evaluate the potential relationship between AT and comorbidities.</citation_analysis></p>
      <p><citation_analysis attribute="negative">OSA is an independent risk factor for a number of comorbidities, strongly associated with higher rates of cardiovascular mortality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="negative"> However, there are few clinical indicators for identifying the presence of comorbidities in OSA. Arousal threshold is a new indicator to assess the endotype of OSA, which contributes to increased duration of nocturnal apnea, and the potential mechanisms may involve altered central chemosensitivity and upper airway collapse, dysfunction of peripheral mechanoreceptors, or altered mechanisms of arousal.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="positive"> According to the gold standard for measuring AT, patients with OSA and high AT need increased stimuli (ie, respiratory drive and negative chest pressure) for achieving arousal, requiring an increase in the recruitment of upper airway dilators, which subsequently result in prolonged duration of respiratory events, lower oxygen saturation, hypercapnia and sympathetic activation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither"> Although AT means the average negative chest pressure before cortical awakenings, which indicates that it would be more difficult to wake up during a respiratory event, there is no absolute dose effect between AT and the number of arousals. For one thing, short-term arousals may be frequently occurred, served as a protective factor for alleviating severe respiratory events and restoring ventilation, especially in those with high AHI (or more obstructive events) and obesity hypoventilation syndrome.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> For another, pharyngeal vibration or the loud noise before airway opening can contribute to the arousals in some patients with severe obstructive events.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither"> Therefore, patients with high AT may suffer from high AHI due to more severe upper airway collapse, with louder snoring and greater intensity of upper airway muscle vibration, leading to more arousals and sleep fragmentation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> In addition, chronic intermittent hypoxia induced by OSA leads to hyperactivation of the carotid body (CB), which reflexively causes sympathetic excitation and makes a contribution to the maintenance of glucose homeostasis.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither"> CB chemoreceptor dysregulation may be one of the mechanisms mediating the co-occurrence of OSA with diabetes and hypertension.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither"> These mechanisms are possible mediators of the association between high AT and the higher occurrence of comorbidities. Meanwhile, whether the intensity of arousal has an additional effect on the occurrence of comorbidities, and whether the distribution of arousal types is different between patients with low and high AT is still unknown, which needs more studies to demonstrate.</citation_analysis></p>
      <p><citation_analysis attribute="positive">This study showed that high AT was significantly and positively associated with the occurrence of hypertension in patients with OSA. Previous studies have reported that sleep-related hypoxia indicators such as T90% and hypoxic burden have the similar association.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither"> Hypoxia causes an increase in nocturnal blood pressure by promoting cortex arousals and inducing sympathetic nervous activity, which may eventually lead to resistant hypertension.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="positive"> In addition to prolonged and deeper hypoxia, increased negative intrathoracic pressure and respiratory effort due to elevated AT not only produce sympathetic activation and hypercapnia, but also significant shear stress and vascular wall remodeling, which are also potential mechanisms favoring the development of hypertension.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="positive"> On the other side, our subgroup analyses indicated that the positive association between high AT and hypertension was only observed in male patients with less obese and young age. A possible explanation could be that progesterone and estrogen in women augment the arousal response to transient hyperventilation and hypercapnia associated with apneic episodes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> However, the interaction between high AT and low obesity (or young age) in patients with OSA and hypertension is unclear.</citation_analysis></p>
      <p><citation_analysis attribute="positive">There were a number of longitudinal cohort studies indicating a significant association between OSA and increasing risk of diabetes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither"> The precise pathophysiological and causative correlation between dysregulated glucose metabolism and obstructive sleep apnea (OSA) remain uncertain. Several potential mechanisms, including OSA-induced intermittent hypoxia, hypercapnia, sympathetic arousal, sleep fragmentation, and inflammation, make contributions to insulin resistance and β-cell dysfunction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="positive"> The study by Oltmanns KM et al demonstrated that the severity of hypoxia and the duration of exposure may have an adverse impact on insulin sensitivity. Muraki et al reported that nocturnal intermittent hypoxia in OSA (ODI ≥ 15) was positively associated with diabetes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> For another, the CB chemoreceptor dysregulation due to OSA-induced hypercapnia and hypoxia mediates insulin resistance and dysglycemia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="positive"> It has been shown that sympathetic activation is observed in patients with type 2 diabetes, and that high plasma insulin levels and insulin resistance are closely related and interact with each other.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0048" ref-type="bibr">48</xref></citation_analysis><citation_analysis attribute="neither"> Sympathetic excitation causes adrenaline release, which decreases glucose metabolism and decreases insulin-mediated glucose uptake in skeletal muscle cells, causing insulin resistance.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="neither"> In theory, patients with OSA and higher AT have lower oxygen saturation, more arousals for ventilation restore and more severe hypercapnia, with prolonged respiratory events. Thus, AT may be a more comprehensive indicator for better assessing the relationship between OSA and diabetes than AHI, which as our study showed.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Low AT is considered to be one of the most important endotypes in OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> Nevertheless, there is no clear definition for the remaining OSA population with non-low AT. In our study, based on AT scores, we found that compared to low or high AT, very high AT (AT scores ≥ 30) seemed to be an another pathophysiological feature, closely associated with hypertension and diabetes. As low and very high AT are related to various complications in OSA, it is possible that the high AT (15 ≤ AT score &lt; 30) is the normal AT level range, similar to blood pressure and glucose, which can be classified into three levels. This hypothesis requires more prospective studies to compare the prognosis of patients with different AT levels by means of measuring intrathoracic negative pressure.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Previous research indicated AT was found to drop during continuous positive airway pressure (CPAP) therapy, supporting the theory that more severe OSA is associated with higher AT.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="positive"> By lowering the AT to normal levels, we hypothesize that the duration of airway obstruction becomes shorter and carotid body modulation is more stable, with reduced hypoxia, carbon dioxide retention and sympathetic activation, which needs to be proven by more research. According to our study, the coexistence of diabetes and hypertension were more observed in patients with higher AT, which highlights the necessity for them to be evaluated as suitable candidates for receiving CPAP therapy. It has been suggested that CPAP treatment could significantly reduce blood pressure, plasma norepinephrine and sympathetic activity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="neither"> Above all, the classification of participants based on AHI may not effectively identify individuals at the higher prevalence of comorbid hypertension and diabetes. Prospectively accessing the AT of patients with OSA may help determine whether individuals with a higher AT benefit more from CPAP than those with a lower AT.</citation_analysis></p>
      <p><citation_analysis attribute="positive">There are some limitations in our study. Firstly, it was a retrospective study and could not determine the causation between high AT and other comorbidities. For another, some patients in retrospective study may be missed for hypertension and other complications, which can lead to an underestimation of true effect. Secondly, the definition of high AT and the measurement of AT score were based on previous studies, instead of the gold standard. Moreover, we did not record the medication history of included patients for hypertension and diabetes, which may influence the results to some extent.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Conclusions</title>
      <p><citation_analysis attribute="neither">High AT is significantly associated with increased prevalent hypertension and diabetes in patients with OSA. Compared with AHI, AT score is a potentially comprehensive indicator for better evaluating the relationship between OSA and related comorbidities. More large-scale studies are needed to verify the application value of AT score and the correlation between AT and comorbidities in OSA.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">We would like to thank Professor Nanshan Zhong from State Key Laboratory of Respiratory Disease for the constructive advice he gave. We thank Home for Researchers editorial team for language editing service.</citation_analysis></p>
    </ack>
    <sec sec-type="data-availability" id="s0006">
      <title>Data Sharing Statement</title>
      <p><citation_analysis attribute="positive">The data used to support the findings of this study are available from the corresponding author upon request.</citation_analysis></p>
    </sec>
    <sec sec-type="COI-statement" id="s0007">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors have no conflicts of interest to report for this work.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Benjafield</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Ayas</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Eastwood</surname>
<given-names>PR</given-names></string-name>, et al. <article-title>Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis</article-title>. <source><italic toggle="yes">Lancet Respir Med</italic></source>. <year>2019</year>;<volume>7</volume>(<issue>8</issue>):<fpage>687</fpage>–<lpage>698</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2213-2600(19)30198-5</pub-id><pub-id pub-id-type="pmid">31300334</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Yenokyan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Newman</surname>
<given-names>AB</given-names></string-name>, et al. <article-title>Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2010</year>;<volume>122</volume>(<issue>4</issue>):<fpage>352</fpage>–<lpage>360</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.901801</pub-id><pub-id pub-id-type="pmid">20625114</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xu</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Hui</surname>
<given-names>CKM</given-names></string-name>, <string-name><surname>Lui</surname>
<given-names>MMS</given-names></string-name>, <string-name><surname>Lam</surname>
<given-names>DCL</given-names></string-name>, <string-name><surname>Fong</surname>
<given-names>DYT</given-names></string-name>, <string-name><surname>Ip</surname>
<given-names>MSM</given-names></string-name>. <article-title>Incident type 2 diabetes in OSA and effect of CPAP treatment: a retrospective clinic cohort study</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2019</year>;<volume>156</volume>(<issue>4</issue>):<fpage>743</fpage>–<lpage>753</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2019.04.130</pub-id><pub-id pub-id-type="pmid">31128116</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Marin</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Carrizo</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Vicente</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Agusti</surname>
<given-names>AG</given-names></string-name>. <article-title>Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2005</year>;<volume>365</volume>(<issue>9464</issue>):<fpage>1046</fpage>–<lpage>1053</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(05)71141-7</pub-id><pub-id pub-id-type="pmid">15781100</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Qaseem</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dallas</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Owens</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Starkey</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Holty</surname>
<given-names>JEC</given-names></string-name>, <string-name><surname>Shekelle</surname>
<given-names>P</given-names></string-name>. <article-title>Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from theAmerican college of physicians</article-title>. <source><italic toggle="yes">Ann Intern Med</italic></source>. <year>2014</year>;<volume>161</volume>(<issue>3</issue>):<fpage>210</fpage>. doi:<pub-id pub-id-type="doi">10.7326/M12-3187</pub-id><pub-id pub-id-type="pmid">25089864</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Højager</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schoos</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Tingsgaard</surname>
<given-names>PK</given-names></string-name>, <string-name><surname>Bock</surname>
<given-names>TG</given-names></string-name>, <string-name><surname>Homøe</surname>
<given-names>P</given-names></string-name>. <article-title>Estimates of 10-year risk of cardiovascular death and adherence to cardiovascular risk factor management in Danish patients investigated for obstructive sleep apnea</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2023</year>;<volume>104</volume>:<fpage>22</fpage>–<lpage>28</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2023.02.009</pub-id><pub-id pub-id-type="pmid">36870324</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Azarbarzin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sands</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Stone</surname>
<given-names>KL</given-names></string-name>, et al. <article-title>The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the osteoporotic fractures in men study and the sleep heart health study</article-title>. <source><italic toggle="yes">Eur Heart J</italic></source>. <year>2019</year>;<volume>40</volume>(<issue>14</issue>):<fpage>1149</fpage>–<lpage>1157</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehy624</pub-id><pub-id pub-id-type="pmid">30376054</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Guo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>Y</given-names></string-name>. <article-title>New metrics from polysomnography: precision medicine for OSA interventions</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2023</year>;<volume>Volume 15</volume>:<fpage>69</fpage>–<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S400048</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Labarca</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Vena</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>WH</given-names></string-name>, et al. <article-title>Sleep apnea physiological burdens and cardiovascular morbidity and mortality</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2023</year>;<volume>208</volume>(<issue>7</issue>):<fpage>802</fpage>–<lpage>813</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.202209-1808OC</pub-id><pub-id pub-id-type="pmid">37418748</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cao</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>Y</given-names></string-name>. <article-title>The association between sleep breathing impairment index and cardiovascular risk in male patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2022</year>;<volume>Volume 14</volume>:<fpage>53</fpage>–<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S343661</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Trzepizur</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Blanchard</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ganem</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Sleep apnea-specific hypoxic burden, symptom subtypes, and risk of cardiovascular events and all-cause mortality</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2022</year>;<volume>205</volume>(<issue>1</issue>):<fpage>108</fpage>–<lpage>117</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.202105-1274OC</pub-id><pub-id pub-id-type="pmid">34648724</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Eckert</surname>
<given-names>DJ</given-names></string-name>. <article-title>Phenotypic approaches to obstructive sleep apnoea - new pathways for targeted therapy</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2018</year>;<volume>37</volume>:<fpage>45</fpage>–<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2016.12.003</pub-id><pub-id pub-id-type="pmid">28110857</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Eckert</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>White</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Jordan</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Malhotra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wellman</surname>
<given-names>A</given-names></string-name>. <article-title>Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2013</year>;<volume>188</volume>(<issue>8</issue>):<fpage>996</fpage>–<lpage>1004</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201303-0448OC</pub-id><pub-id pub-id-type="pmid">23721582</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zavodny</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Roth</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bassetti</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Mathis</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Douglas</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Gugger</surname>
<given-names>M</given-names></string-name>. <article-title>Effects of sleep fragmentation on the arousability to resistive loading in NREM and REM sleep in normal men</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2006</year>;<volume>29</volume>(<issue>4</issue>):<fpage>525</fpage>–<lpage>532</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/29.4.525</pub-id><pub-id pub-id-type="pmid">16676786</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Antonaglia</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Passuti</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Giudici</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2023</year>;<volume>27</volume>(<issue>3</issue>):<fpage>933</fpage>–<lpage>941</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-022-02665-4</pub-id><pub-id pub-id-type="pmid">35907116</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yamaguchi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shiota</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kusunoki</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Polysomnographic features of low arousal threshold in overlap syndrome involving obstructive sleep apnea and chronic obstructive pulmonary disease</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2019</year>;<volume>23</volume>(<issue>4</issue>):<fpage>1095</fpage>–<lpage>1100</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-019-01786-7</pub-id><pub-id pub-id-type="pmid">30685846</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hang</surname>
<given-names>LW</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>WJ</given-names></string-name>. <article-title>Clinical characteristics of Asian patients with sleep apnea with low arousal threshold and sleep structure change with continuous positive airway pressure</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2021</year>;<volume>25</volume>(<issue>3</issue>):<fpage>1309</fpage>–<lpage>1317</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-020-02235-6</pub-id><pub-id pub-id-type="pmid">33123927</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ayas</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Shea</surname>
<given-names>SA</given-names></string-name>. <article-title>Hypercapnia can induce arousal from sleep in the absence of altered respiratory mechanoreception</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2000</year>;<volume>162</volume>(<issue>3</issue>):<fpage>1004</fpage>–<lpage>1008</lpage>. doi:<pub-id pub-id-type="doi">10.1164/ajrccm.162.3.9908040</pub-id><pub-id pub-id-type="pmid">10988121</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heinzer</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>White</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Jordan</surname>
<given-names>AS</given-names></string-name>, et al. <article-title>Trazodone increases arousal threshold in obstructive sleep apnoea</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2008</year>;<volume>31</volume>(<issue>6</issue>):<fpage>1308</fpage>–<lpage>1312</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00067607</pub-id><pub-id pub-id-type="pmid">18256066</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Eckert</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Younes</surname>
<given-names>MK</given-names></string-name>. <article-title>Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment</article-title>. <source><italic toggle="yes">J Appl Physiol</italic></source>. <year>2014</year>;<volume>116</volume>(<issue>3</issue>):<fpage>302</fpage>–<lpage>313</lpage>. doi:<pub-id pub-id-type="doi">10.1152/japplphysiol.00649.2013</pub-id><pub-id pub-id-type="pmid">23990246</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kario</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hettrick</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Prejbisz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Januszewicz</surname>
<given-names>A</given-names></string-name>. <article-title>Obstructive sleep apnea–induced neurogenic nocturnal hypertension: a potential role of renal denervation?</article-title>
<source><italic toggle="yes">Hypertension</italic></source>. <year>2021</year>;<volume>77</volume>(<issue>4</issue>):<fpage>1047</fpage>–<lpage>1060</lpage>. doi:<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.16378</pub-id><pub-id pub-id-type="pmid">33641363</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zinchuk</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Jeon</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Prevalence, associated clinical features, and impact on continuous positive airway pressure use of a low respiratory arousal threshold among male United States veterans with obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2018</year>;<volume>14</volume>(<issue>05</issue>):<fpage>809</fpage>–<lpage>817</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.7112</pub-id><pub-id pub-id-type="pmid">29734986</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bakris</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ali</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Parati</surname>
<given-names>G</given-names></string-name>. <article-title>ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison</article-title>. <source><italic toggle="yes">J Am Coll Cardiol</italic></source>. <year>2019</year>;<volume>73</volume>(<issue>23</issue>):<fpage>3018</fpage>–<lpage>3026</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jacc.2019.03.507</pub-id><pub-id pub-id-type="pmid">31196460</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><collab>American Diabetes Association. 2</collab>. <article-title>Classification and diagnosis of diabetes: standards of medical care in diabetes—2018</article-title>. <source><italic toggle="yes">Diabetes Care</italic></source>. <year>2018</year>;<volume>41</volume>(<issue>Supplement_1</issue>):<fpage>S13</fpage>–<lpage>S27</lpage>. doi:<pub-id pub-id-type="doi">10.2337/dc18-S002</pub-id>.<pub-id pub-id-type="pmid">29222373</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>D’Agostino</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Vasan</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Pencina</surname>
<given-names>MJ</given-names></string-name>, et al. <article-title>General cardiovascular risk profile for use in primary care: the Framingham heart study</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2008</year>;<volume>117</volume>(<issue>6</issue>):<fpage>743</fpage>–<lpage>753</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.699579</pub-id><pub-id pub-id-type="pmid">18212285</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Berry</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Budhiraja</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, et al. <article-title>Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. deliberations of the sleep apnea definitions task force of the American academy of sleep medicine</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2012</year>;<volume>08</volume>(<issue>05</issue>):<fpage>597</fpage>–<lpage>619</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.2172</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Berry</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Brooks</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gamaldo</surname>
<given-names>C</given-names></string-name>, et al. <article-title>AASM scoring manual updates for 2017 (Version 2.4)</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2017</year>;<volume>13</volume>(<issue>5</issue>):<fpage>665</fpage>–<lpage>666</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.6576</pub-id><pub-id pub-id-type="pmid">28416048</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Prevalence, characteristics, and respiratory arousal threshold of positional obstructive sleep apnea in China: a large scale study from shanghai sleep health study cohort</article-title>. <source><italic toggle="yes">Respir Res</italic></source>. <year>2022</year>;<volume>23</volume>(<issue>1</issue>):<fpage>240</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12931-022-02141-3</pub-id><pub-id pub-id-type="pmid">36096792</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>JJ</given-names></string-name>, et al. <article-title>Reduced cortical arousability to nocturnal apneic episodes in patients with wake-up ischemic stroke</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2020</year>;<volume>66</volume>:<fpage>252</fpage>–<lpage>258</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2019.09.007</pub-id><pub-id pub-id-type="pmid">32008889</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Edwards</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Eckert</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>McSharry</surname>
<given-names>DG</given-names></string-name>, et al. <article-title>Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2014</year>;<volume>190</volume>(<issue>11</issue>):<fpage>1293</fpage>–<lpage>1300</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201404-0718OC</pub-id><pub-id pub-id-type="pmid">25321848</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Thomson</surname>
<given-names>LDJ</given-names></string-name>, <string-name><surname>Landry</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Singleton</surname>
<given-names>R</given-names></string-name>, et al. <article-title>The effect of hypopnea scoring on the arousal threshold in patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2020</year>;<volume>202</volume>(<issue>9</issue>):<fpage>1308</fpage>–<lpage>1311</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.202003-0589LE</pub-id><pub-id pub-id-type="pmid">32551850</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><article-title>Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. the report of an American academy of sleep medicine task force</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>1999</year>;<volume>22</volume>(<issue>5</issue>):<fpage>667</fpage>–<lpage>689</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/22.5.667</pub-id><pub-id pub-id-type="pmid">10450601</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ni</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>. <article-title>Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: a cross-sectional study</article-title>. <source><italic toggle="yes">Environ Health Preventative Med</italic></source>. <year>2017</year>;<volume>22</volume>(<issue>1</issue>):<fpage>19</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12199-017-0634-7</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Labarca</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Campos</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Thibaut</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Dreyse</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jorquera</surname>
<given-names>J</given-names></string-name>. <article-title>Do T90 and SaO2 nadir identify a different phenotype in obstructive sleep apnea?</article-title>
<source><italic toggle="yes">Sleep Breath</italic></source>. <year>2019</year>;<volume>23</volume>(<issue>3</issue>):<fpage>1007</fpage>–<lpage>1010</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-019-01860-0</pub-id><pub-id pub-id-type="pmid">31081538</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sforza</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Krieger</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Petiau</surname>
<given-names>C</given-names></string-name>. <article-title>Nocturnal evolution of respiratory effort in obstructive sleep apnoea syndrome: influence on arousal threshold</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>1998</year>;<volume>12</volume>(<issue>6</issue>):<fpage>1257</fpage>–<lpage>1263</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.98.12061257</pub-id><pub-id pub-id-type="pmid">9877474</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Younes</surname>
<given-names>M</given-names></string-name>. <article-title>Role of arousals in the pathogenesis of obstructive sleep apnea</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2004</year>;<volume>169</volume>(<issue>5</issue>):<fpage>623</fpage>–<lpage>633</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.200307-1023OC</pub-id><pub-id pub-id-type="pmid">14684560</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kohler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Stradling</surname>
<given-names>JR</given-names></string-name>. <article-title>Mechanisms of vascular damage in obstructive sleep apnea</article-title>. <source><italic toggle="yes">Nat Rev Cardiol</italic></source>. <year>2010</year>;<volume>7</volume>(<issue>12</issue>):<fpage>677</fpage>–<lpage>685</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrcardio.2010.145</pub-id><pub-id pub-id-type="pmid">21079639</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Conde</surname>
<given-names>SV</given-names></string-name>, <string-name><surname>Sacramento</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Guarino</surname>
<given-names>MP</given-names></string-name>, et al. <article-title>Carotid body, insulin, and metabolic diseases: unraveling the links</article-title>. <source><italic toggle="yes">Front Physiol</italic></source>. <year>2014</year>;<volume>5</volume>:<fpage>418</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2014.00418</pub-id><pub-id pub-id-type="pmid">25400585</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>hui</surname>
<given-names>WD</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cao</surname>
<given-names>J</given-names></string-name>. <article-title>Time under 90% oxygen saturation and systemic hypertension in patients with obstructive sleep apnea syndrome</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2022</year>;<volume>Volume 14</volume>:<fpage>2123</fpage>–<lpage>2132</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S388238</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Brown</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yazdi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Jodari-Karimi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Owen</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Reisin</surname>
<given-names>E</given-names></string-name>. <article-title>Obstructive sleep apnea and hypertension: updates to a critical relationship</article-title>. <source><italic toggle="yes">Curr Hypertens Rep</italic></source>. <year>2022</year>;<volume>24</volume>(<issue>6</issue>):<fpage>173</fpage>–<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11906-022-01181-w</pub-id><pub-id pub-id-type="pmid">35246797</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Eskandari</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Zou</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Grote</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Penzel</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hedner</surname>
<given-names>J</given-names></string-name>. <article-title>Independent associations between arterial bicarbonate, apnea severity and hypertension in obstructive sleep apnea</article-title>. <source><italic toggle="yes">Respir Res</italic></source>. <year>2017</year>;<volume>18</volume>(<issue>1</issue>):<fpage>130</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12931-017-0607-9</pub-id><pub-id pub-id-type="pmid">28659192</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Martinot</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Le-Dong</surname>
<given-names>NN</given-names></string-name>, <string-name><surname>Malhotra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pépin</surname>
<given-names>JL</given-names></string-name>. <article-title>Respiratory effort during sleep and prevalent hypertension in obstructive sleep apnoea</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2023</year>;<volume>61</volume>(<issue>3</issue>):<fpage>2201486</fpage>. doi:<pub-id pub-id-type="doi">10.1183/13993003.01486-2022</pub-id><pub-id pub-id-type="pmid">36455958</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Behan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wenninger</surname>
<given-names>JM</given-names></string-name>. <article-title>Sex steroidal hormones and respiratory control</article-title>. <source><italic toggle="yes">Respir Physiol Neurobiol</italic></source>. <year>2008</year>;<volume>164</volume>(<issue>1–2</issue>):<fpage>213</fpage>–<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.resp.2008.06.006</pub-id><pub-id pub-id-type="pmid">18599386</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Marshall</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>KKH</given-names></string-name>, <string-name><surname>Phillips</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>PY</given-names></string-name>, <string-name><surname>Knuiman</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Grunstein</surname>
<given-names>RR</given-names></string-name>. <article-title>Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?</article-title>
<source><italic toggle="yes">J Clin Sleep Med JCSM off Publ Am Acad Sleep Med</italic></source>. <year>2009</year>;<volume>5</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>20</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Reutrakul</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mokhlesi</surname>
<given-names>B</given-names></string-name>. <article-title>Obstructive sleep apnea and diabetes: a state of the art review</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2017</year>;<volume>152</volume>(<issue>5</issue>):<fpage>1070</fpage>–<lpage>1086</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2017.05.009</pub-id><pub-id pub-id-type="pmid">28527878</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Muraki</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Tanigawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yamagishi</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Nocturnal intermittent hypoxia and metabolic syndrome; the effect of being overweight: the CIRCS study</article-title>. <source><italic toggle="yes">J Atheroscler Thromb</italic></source>. <year>2010</year>;<volume>17</volume>(<issue>4</issue>):<fpage>369</fpage>–<lpage>377</lpage>. doi:<pub-id pub-id-type="doi">10.5551/jat.3319</pub-id><pub-id pub-id-type="pmid">20103974</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Joon Yun</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>PY</given-names></string-name>, <string-name><surname>Bazar</surname>
<given-names>KA</given-names></string-name>. <article-title>Autonomic dysregulation as a basis of cardiovascular, endocrine, and inflammatory disturbances associated with obstructive sleep apnea and other conditions of chronic hypoxia, hypercapnia, and acidosis</article-title>. <source><italic toggle="yes">Med Hypotheses</italic></source>. <year>2004</year>;<volume>62</volume>(<issue>6</issue>):<fpage>852</fpage>–<lpage>856</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0306-9877(03)00322-0</pub-id><pub-id pub-id-type="pmid">15142635</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Grassi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Biffi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dell’Oro</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">J Hypertens</italic></source>. <year>2020</year>;<volume>38</volume>(<issue>8</issue>):<fpage>1436</fpage>–<lpage>1442</lpage>. doi:<pub-id pub-id-type="doi">10.1097/HJH.0000000000002431</pub-id><pub-id pub-id-type="pmid">32371764</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jamerson</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Julius</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gudbrandsson</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Andersson</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Brant</surname>
<given-names>DO</given-names></string-name>. <article-title>Reflex sympathetic activation induces acute insulin resistance in the human forearm</article-title>. <source><italic toggle="yes">Hypertension</italic></source>. <year>1993</year>;<volume>21</volume>(<issue>5</issue>):<fpage>618</fpage>–<lpage>623</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.hyp.21.5.618</pub-id><pub-id pub-id-type="pmid">8491496</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hedner</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Darpö</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Ejnell</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Carlson</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Caidahl</surname>
<given-names>K</given-names></string-name>. <article-title>Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications</article-title>. <source><italic toggle="yes">European Respiratory Journal</italic></source>. <year>1995</year>;<volume>8</volume>(<issue>2</issue>):<fpage>222</fpage>–<lpage>229</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.95.08020222</pub-id><pub-id pub-id-type="pmid">7758555</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mills</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Kennedy</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>Loredo</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Dimsdale</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Ziegler</surname>
<given-names>MG</given-names></string-name>. <article-title>Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Appl Physiol</italic></source>. <year>2006</year>;<volume>100</volume>(<issue>1</issue>):<fpage>343</fpage>–<lpage>348</lpage>. doi:<pub-id pub-id-type="doi">10.1152/japplphysiol.00494.2005</pub-id><pub-id pub-id-type="pmid">16357087</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
